Cell therapy from fat tissue for autoimmune dry mouth
Part of Mouth & dental clinical trials.
This Phase 1/2 study tests a new cell-based treatment made from a patient’s own fat tissue to improve autoimmune dry mouth (xerostomia). It focuses first on safety, and also looks for early signs that saliva and dry-mouth symptoms may improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Have autoimmune dry mouth (xerostomia), including Sjögren’s disease or a related autoimmune condition
- Your dry mouth severity score must be at least 30 out of 60 on a questionnaire
- Have no major ongoing infection and test negative for certain viruses (HIV, hepatitis B/C, etc.)
- If you can become pregnant: use effective birth control and have a negative pregnancy test; do not breastfeed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using special cells (mesenchymal stromal cells) from your own bone marrow to help with dry mouth that is not caused by radiation. The goal is to see if it can increase saliva production and improve quality of life.
This study tests whether “photobiomodulation” light therapy, guided by a phone app, can improve chronic dry mouth (xerostomia) in people who finished radiation for head and neck cancer. It may help reduce bothersome mouth dryness and support better day-to-day comfort after treatment.
This study tests whether injections of hyaluronic acid—a naturally occurring substance—can relieve chronic dry mouth (xerostomia). If it works, it could offer a new treatment option for people who have had dry mouth for at least a year.
This Phase 1 study tests whether a citrus-flavored supplement (d-limonene gelcaps) can help prevent or reduce dry mouth (xerostomia) in people getting radiation plus chemotherapy for certain head and neck cancers. It aims to see how well the approach is tolerated and whether it can protect saliva function during treatment.
This trial tests if injecting fat-derived stem cells into the salivary glands can help relieve dry mouth in people with Sjögren's disease. It aims to improve saliva flow and reduce discomfort.
This trial tests whether repeated injections of stem cells (mesenchymal stem cells) can help people who have chronic dry mouth after radiation therapy for head or neck cancer. The goal is to improve saliva production and reduce discomfort.
Hear when a new Xerostomia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.